The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatment.EBI
Wuxi Apptec (Shanghai)
Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver disease.EBI
Wuxi Apptec (Shanghai)
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMD.EBI
Wuxi Apptec (Shanghai)
Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia.EBI
Wuxi Apptec (Shanghai)
Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH.EBI
Wuxi Apptec (Shanghai)
Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-EBI
Wuxi Apptec (Shanghai)
Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.EBI
Wuxi Apptec (Shanghai)
Discovery and optimization of selective FGFR4 inhibitors via scaffold hopping.EBI
Wuxi Apptec (Shanghai)
The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia.EBI
Wuxi Apptec (Shanghai)
Compositions and methods for treating neoplasia, inflammatory disease and other disordersBDB
Dana-Farber Cancer Institute